Distinct mechanisms of cell in breast cancer and their clinical implication
Aodi Li1, Sishi Liu2, Ying Xuan3
1Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning Province, China.
Abstract:
Breast cancer is a heterogeneous disease affecting women globally. Despite significant advancements in therapeutic interventions in recent years, breast cancer remains a leading cause of cancer-related morbidity in women. Breast cancer's diverse molecular subtypes and escalating complexities in targeted therapies underscore the imperative need to explore novel therapeutic targets. The obstruction of apoptosis and the suppression of cell death are hallmarks of malignant tumors. Cell death, a pivotal regulatory event during tumorigenesis, includes apoptosis, anoikis, autophagy, necroptosis, ferroptosis, pyroptosis, and cuproptosis. This review systematically dissects the molecular underpinnings of cell death pathways in breast cancer, offering novel mechanistic insights and therapeutic opportunities to inform clinical management strategies.
Insights
This review explores cell death pathways in breast cancer, highlighting their role in tumor progression. Understanding these mechanisms offers new therapeutic targets for breast cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Biology
Background:
- Breast cancer is a globally prevalent, heterogeneous disease with significant morbidity.
- Despite therapeutic advances, novel targets are crucial due to molecular diversity and treatment complexity.
- Hallmarks of cancer include suppressed cell death, necessitating exploration of various cell death modalities.
Purpose of the Study:
- To systematically review the molecular mechanisms of diverse cell death pathways in breast cancer.
- To identify novel therapeutic targets and strategies based on cell death modulation.
- To provide insights for improved clinical management of breast cancer.
Main Methods:
- Systematic literature review of cell death pathways in breast cancer.
- Analysis of molecular underpinnings of apoptosis, anoikis, autophagy, necroptosis, ferroptosis, pyroptosis, and cuproptosis.
- Integration of findings to identify therapeutic opportunities.
Main Results:
- Cell death pathways are critically implicated in breast cancer development and progression.
- Targeting specific cell death mechanisms presents promising therapeutic avenues.
- Dysregulation of apoptosis and other cell death forms contributes to treatment resistance.
Conclusions:
- Modulating cell death pathways offers a promising strategy for novel breast cancer therapies.
- Further research into the intricate roles of diverse cell death types is warranted.
- Translating mechanistic insights into clinical practice can enhance breast cancer management.
More Related Videos
07:03Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples
Published on: October 2, 2020
09:44Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior
Published on: June 13, 2016
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mitogens and the Cell Cycle
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
The Tumor Microenvironment
